Committed to
A Better, Safer Prostate Biopsy

Committed to
A Better, Safer Prostate Biopsy

“Like all cancers, screening is key and early detection makes a difference. PrecisionPoint™ can provide better and earlier detection of prostate cancer, allowing patients to start treatment sooner and improve their outcomes.”

Dr. Matthew Allaway, Founder, Perineologic

“Like all cancers, screening is key and early detection makes a difference. PrecisionPoint™ can provide better and earlier detection of prostate cancer, allowing patients to start treatment sooner and improve their outcomes.”

Dr. Matthew Allaway, Founder, Perineologic

Now there is a better option…

BENEFITS of OUR Approach

  • Improved Cancer Detection

  • No Bowel Prep

  • Speedy Recovery

  • Made In The USA

BENEFITS of OUR Approach

  • Improved Cancer Detection

  • No Bowel Prep

  • Speedy Recovery

  • Made In The USA

“I tell everyone I know who needs a biopsy: You don’t want the transrectal biopsy, you want the best that is available. With the PrecisionPoint™, my doctor was able to find the cancer.

Dr. Jim Kidd, patient

“I tell everyone I know who needs a biopsy: You don’t want the transrectal biopsy, you want the best that is available. With the PrecisionPoint™, my doctor was able to find the cancer.

Dr. Jim Kidd, patient

What Is PrecisionPoint™?

The PrecisionPoint™ Transperineal Access System (PPTAS) is the first FDA cleared device allowing free-handed transperineal biopsy of the prostate. The device and technique eliminate the need for bowel prep and antibiotics prior to the prostate biopsy.

The procedure allows access to the prostate through the perineum or “taint”, avoiding the rectum completely. The procedure takes 15-20 minutes and can be performed under local or twilight anesthesia.

A recent study published in the British Journal of Urology found that 94% of missed cancers after transrectal prostate biopsies were located in the anterior region of the prostate. The PrecisionPoint™ Transperineal Access System allows strategic sampling of the anterior portion of the prostate where these missed cancers have been found.

At Perineologic , we understand your concern about the possibility of having prostate cancer. Your urologist is trained to perform a better, safer prostate biopsy using the PrecisionPoint™ Transperineal Access System.

What Is PrecisionPoint™?

The PrecisionPoint™ Transperineal Access System (PPTAS) is the first FDA cleared device allowing free-handed transperineal biopsy of the prostate. The device and technique eliminate the need for bowel prep and antibiotics prior to the prostate biopsy.

The procedure allows access to the prostate through the perineum or “taint”, avoiding the rectum completely. The procedure takes 15-20 minutes and can be performed under local or twilight anesthesia.

A recent study published in the British Journal of Urology found that 94% of missed cancers after transrectal prostate biopsies were located in the anterior region of the prostate. The PrecisionPoint™ Transperineal Access System allows strategic sampling of the anterior portion of the prostate where these missed cancers have been found.

At Perineologic , we understand your concern about the possibility of having prostate cancer. Your urologist is trained to perform a better, safer prostate biopsy using the PrecisionPoint™ Transperineal Access System.

PrecisionPoint™ is Revolutionizing Prostate Biopsy…

Due to its safety and effectiveness, this state-of-the-art approach is being rapidly adopted around the world.

PrecisionPoint™ Procedures Performed Worldwide

Read The Latest News About PrecisionPoint™ and Perineologic.

VISIT THE MEDIA CENTER

Have a Question? Contact Us!

Thank you for your interest in Perineologic!

    Other Ways to Contact Us

    • (240) 727-7662

    • john@perineologic.com

    • Perineologic
      183 N. Centre Street
      Cumberland, MD 21502
      United States

    MEDIA CENTER : PrecisionPoint™ and Related Topics

    MEDIA CENTER : PrecisionPoint™ and Related Topics

    ML-001-01revC